These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23410241)
1. In silico comparison of antimycobacterial natural products with known antituberculosis drugs. Espinoza-Moraga M; Njuguna NM; Mugumbate G; Caballero J; Chibale K J Chem Inf Model; 2013 Mar; 53(3):649-60. PubMed ID: 23410241 [TBL] [Abstract][Full Text] [Related]
2. Antitubercular Marine Natural Products. Wang L; Wang J; Liu J; Liu Y Curr Med Chem; 2018; 25(20):2304-2328. PubMed ID: 28088903 [TBL] [Abstract][Full Text] [Related]
3. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis. Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220 [TBL] [Abstract][Full Text] [Related]
4. Molecular Docking Suggests the Targets of Anti-Mycobacterial Natural Products. Baptista R; Bhowmick S; Shen J; Mur LAJ Molecules; 2021 Jan; 26(2):. PubMed ID: 33477495 [TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
6. Prioritization of natural compounds against mycobacterium tuberculosis 3-dehydroquinate dehydratase: A combined in-silico and in-vitro study. Lone MY; Athar M; Gupta VK; Jha PC Biochem Biophys Res Commun; 2017 Sep; 491(4):1105-1111. PubMed ID: 28789944 [TBL] [Abstract][Full Text] [Related]
7. Natural antimicrobial peptides against Mycobacterium tuberculosis. Abedinzadeh M; Gaeini M; Sardari S J Antimicrob Chemother; 2015 May; 70(5):1285-9. PubMed ID: 25681127 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin. Mutai P; Pavadai E; Wiid I; Ngwane A; Baker B; Chibale K Bioorg Med Chem Lett; 2015 Jun; 25(12):2510-3. PubMed ID: 25977095 [TBL] [Abstract][Full Text] [Related]
9. Predicting natural product value, an exploration of anti-TB drug space. Dashti Y; Grkovic T; Quinn RJ Nat Prod Rep; 2014 Aug; 31(8):990-8. PubMed ID: 24881816 [TBL] [Abstract][Full Text] [Related]
10. Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2. Billones JB; Carrillo MC; Organo VG; Macalino SJ; Sy JB; Emnacen IA; Clavio NA; Concepcion GP Drug Des Devel Ther; 2016; 10():1147-57. PubMed ID: 27042006 [TBL] [Abstract][Full Text] [Related]
11. Natural products as leads for tuberculosis drug development. Salomon CE; Schmidt LE Curr Top Med Chem; 2012; 12(7):735-65. PubMed ID: 22283816 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in antitubercular natural products. García A; Bocanegra-García V; Palma-Nicolás JP; Rivera G Eur J Med Chem; 2012 Mar; 49():1-23. PubMed ID: 22280816 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of some beta-carboline alkaloids. Begum S; Hassan SI; Siddiqui BS Nat Prod Res; 2004 Aug; 18(4):341-7. PubMed ID: 15214487 [TBL] [Abstract][Full Text] [Related]
14. Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization. Soares de Melo C; Feng TS; van der Westhuyzen R; Gessner RK; Street LJ; Morgans GL; Warner DF; Moosa A; Naran K; Lawrence N; Boshoff HI; Barry CE; Harris CJ; Gordon R; Chibale K Bioorg Med Chem; 2015 Nov; 23(22):7240-50. PubMed ID: 26522089 [TBL] [Abstract][Full Text] [Related]
15. Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system. Bellale E; Naik M; V B V; Ambady A; Narayan A; Ravishankar S; Ramachandran V; Kaur P; McLaughlin R; Whiteaker J; Morayya S; Guptha S; Sharma S; Raichurkar A; Awasthy D; Achar V; Vachaspati P; Bandodkar B; Panda M; Chatterji M J Med Chem; 2014 Aug; 57(15):6572-82. PubMed ID: 24967731 [TBL] [Abstract][Full Text] [Related]
16. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents. Farah SI; Abdelrahman AA; North EJ; Chauhan H Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs. Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082 [TBL] [Abstract][Full Text] [Related]
19. New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold. Pajk S; Živec M; Šink R; Sosič I; Neu M; Chung CW; Martínez-Hoyos M; Pérez-Herrán E; Álvarez-Gómez D; Álvarez-Ruíz E; Mendoza-Losana A; Castro-Pichel J; Barros D; Ballell-Pages L; Young RJ; Convery MA; Encinas L; Gobec S Eur J Med Chem; 2016 Apr; 112():252-257. PubMed ID: 26900657 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of indole-2-carboxamides: a promising class of antituberculosis agents. Kondreddi RR; Jiricek J; Rao SP; Lakshminarayana SB; Camacho LR; Rao R; Herve M; Bifani P; Ma NL; Kuhen K; Goh A; Chatterjee AK; Dick T; Diagana TT; Manjunatha UH; Smith PW J Med Chem; 2013 Nov; 56(21):8849-59. PubMed ID: 24090347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]